With better screening for type 1 diabetes and a new treatment called TZield, the outlook is improving for people with the ...
It’s no secret that as we get older, our bodies start to react differently to the same activities. Clutching the pages of a paperback can cause cramping in the hands. Retrieving groceries from ...
A new study has found that combining the current medications for Alzheimer's disease with small molecules derived from micronutrients found in grapes, berries, peanuts and turmeric is a safer and more ...
Cushing’s disease affects approximately 10 to 15 people per million each year, and occurs more frequently in women WBAL-TV 11 Baltimore Nicole Peace experienced symptoms like dizzy spells and skin ...
The NR3C1 (nuclear receptor subfamily 3 group C member 1) gene encodes the glucocorticoid receptor (GR), a nuclear receptor vital for maintaining physiological homeostasis, and inhibition of NR3C1 ...
PAY ATTENTION TO THEIR HEALTH. IF YOU’VE EVER FELT OFF OR COULDN’T EXPLAIN WHAT YOUR BODY WAS GOING THROUGH, THEN YOU’RE NOT ALONE. ONE WOMAN SHARES HER JOURNEY TO GET ANSWERS IN 2023. NICOLE P ...
WILMINGTON, N.C. (WECT) - Lauren Johnson loves running. The 17-year-old has run countless races and has the bibs to prove it. But for years, Johnson experienced migraines, extreme fatigue, stunted ...
Every Cure is using AI to seek new uses for the roughly 4,000 existing drugs, and cutting traditional preliminary research timelines from as much as 100 days to as little as 17 hours. Treatment for a ...
This symposium reviewed the evolving understanding of the molecular pathophysiology and disease heterogeneity across Alzheimer's disease (AD) and Parkinson's disease (PD). Explored current and ...
New treatments for neurodegenerative diseases like Alzheimer's, Parkinson's, and motor neuron disease (MND) could be unlocked thanks to microscopic medicines developed by researchers at the University ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Mothers from across the country have spoken to Newsweek about their ...
"GLP-1RAs may be considered as adjunctive therapy for the management of obesity and dysglycemia in patients with CS, both in the setting of active disease and after biochemical control of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results